95 related articles for article (PubMed ID: 7618430)
1. New treatment strategies in amyotrophic lateral sclerosis: solutions or illusions?
Robberecht W
Acta Neurol Belg; 1995; 95(2):65-9. PubMed ID: 7618430
[No Abstract] [Full Text] [Related]
2. Amyotrophic lateral sclerosis: theories and therapies.
Rowland LP
Ann Neurol; 1994 Feb; 35(2):129-30. PubMed ID: 8109893
[No Abstract] [Full Text] [Related]
3. [Neurotrophic factors. Therapeutic approach in neurodegenerative diseases].
Wasielewski S
Med Monatsschr Pharm; 1992 Apr; 15(4):98-9. PubMed ID: 1584114
[No Abstract] [Full Text] [Related]
4. Neurotrophic factors in the treatment of motor neuron disease and trauma.
DiStefano PS
Exp Neurol; 1993 Nov; 124(1):56-9. PubMed ID: 8282081
[No Abstract] [Full Text] [Related]
5. The use of trophic factors in degenerative motoneuron diseases.
Yan Q; Miller JA
Exp Neurol; 1993 Nov; 124(1):60-3. PubMed ID: 8282082
[No Abstract] [Full Text] [Related]
6. [Neurotrophic factor treatment in amyotrophic lateral sclerosis].
Tsuzaka K; Mitsumoto H
No To Shinkei; 1998 Jul; 50(7):625-30. PubMed ID: 9739520
[No Abstract] [Full Text] [Related]
7. [Amyotrophic lateral sclerosis].
Moriwaka F
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis--the tools of the trait.
Lederer CW; Santama N
Biotechnol J; 2007 May; 2(5):608-21. PubMed ID: 17345579
[TBL] [Abstract][Full Text] [Related]
9. Overview of the pathogenesis and therapy of amyotrophic lateral sclerosis.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():1-5. PubMed ID: 8787219
[No Abstract] [Full Text] [Related]
10. Amyotrophic lateral sclerosis. A multifactorial disease.
Eisen AA
Adv Neurol; 1995; 68():121-34. PubMed ID: 8787221
[No Abstract] [Full Text] [Related]
11. Drug therapy in amyotrophic lateral sclerosis.
Murray B; Mitsumoto H
Adv Neurol; 2002; 88():63-82. PubMed ID: 11908237
[No Abstract] [Full Text] [Related]
12. Neuron saving schemes.
Lindsay RM
Nature; 1995 Jan; 373(6512):289-90. PubMed ID: 7830762
[No Abstract] [Full Text] [Related]
13. Feasibility of cell therapy for amyotrophic lateral sclerosis.
Garbuzova-Davis S; Sanberg PR
Exp Neurol; 2009 Mar; 216(1):3-6. PubMed ID: 19084005
[No Abstract] [Full Text] [Related]
14. [Amyotrophic lateral sclerosis--its problem].
Mannen T
No To Shinkei; 1992 Jun; 44(6):492-4. PubMed ID: 1389557
[No Abstract] [Full Text] [Related]
15. What's the excitement about excitatory amino acids in amyotrophic lateral sclerosis?
Young AB
Ann Neurol; 1990 Jul; 28(1):9-11. PubMed ID: 2375640
[No Abstract] [Full Text] [Related]
16. [Amyotrophic lateral sclerosis].
Martí-Fàbregas J; Pradas J
Neurologia; 1996 Mar; 11(3):99-108. PubMed ID: 8695148
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis and glutamate--too much of a good thing?
Choi DW
N Engl J Med; 1992 May; 326(22):1493-5. PubMed ID: 1349425
[No Abstract] [Full Text] [Related]
19. Lay-offs follow suspension of clinical trials of protein.
Verrall M
Nature; 1994 Jul; 370(6484):6. PubMed ID: 8015607
[No Abstract] [Full Text] [Related]
20. Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising future.
Choudry RB; Cudkowicz ME
J Clin Pharmacol; 2005 Dec; 45(12):1334-44. PubMed ID: 16291708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
